Skip to main content


About the TRR374 "RENPRO"

In the first funding period (2019 to 2022) of the Collaborative Research Centre 1350, researchers from basic science and clinical disciplines at the University of Regensburg and Friedrich-Alexander-Universit?t Erlangen-Nürnberg joined forces to investigate tubulointerstitium. In the current funding period (2023 to 2026), the successful research of SFB1350 will be continued as Transregio TRR374 RENPRO - funded by the German Research Foundation (DFG (external link, opens in a new window)).

Speaker

Prof. Dr. Mario Schiffer (external link, opens in a new window)
Medical Clinic 4 - Nephrology and Hypertensiology
Ulmenweg 18
D-91054 Erlangen
Phone: ++49 9131/85 39002
E-mail: mario.schiffer@uk-erlangen.de

Scientific Coordinator

Dr. rer. nat. Nina Sopel (external link, opens in a new window)
Medical Clinic 4 - Nephrology and Hypertensiology
Ulmenweg 18
D-91054 Erlangen
Phone: ++49 9131/85 39574
E-mail: Nina.Sopel@uk-erlangen.de 

 

 

Deputy spokespersons

Prof. Dr. Kerstin Amann
Prof. Dr. Frank Schweda
Prof. Dr. Richard Warth

Management Board

Kerstin Amann, Erlangen (deputy spokesperson)
Silke H?rteis, Regensburg
Janina Müller-Deile, Erlangen
Michaela Kritzenberger, Regensburg (equal opportunities officer)
Matthias Mack, Regensburg
Mario Schiffer, Erlangen (spokesperson)
Frank Schweda, Regensburg (deputy spokesperson)
Bettina Firmke (representative of the doctoral students)
Richard Warth, Regensburg (deputy spokesperson)
Michael Wiesener, Erlangen

 

 

To top